These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18350372)

  • 1. Structures and processes in spontaneous ADR reporting systems: a comparative study of Australia and Denmark.
    Aagaard L; Stenver DI; Hansen EH
    Pharm World Sci; 2008 Oct; 30(5):563-70. PubMed ID: 18350372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse drug reaction labelling for atomoxetine, methylphenidate and modafinil: comparison of product information for oral formulations in Australia, Denmark and the United States.
    Aagaard L; Hansen EH
    Curr Drug Saf; 2013 Jul; 8(3):162-8. PubMed ID: 23914751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007.
    Aagaard L; Weber CB; Hansen EH
    Drug Saf; 2010 Apr; 33(4):327-39. PubMed ID: 20297864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creating knowledge about adverse drug reactions: a critical analysis of the Danish reporting system from 1968 to 2005.
    Aagaard L; Soendergaard B; Andersen E; Kampmann JP; Hansen EH
    Soc Sci Med; 2007 Sep; 65(6):1296-309. PubMed ID: 17566621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do pharmaceutical companies handle consumer adverse drug reaction reports? An overview based on a survey of French drug safety managers and officers.
    Fleuranceau-Morel P
    Pharmacoepidemiol Drug Saf; 2002; 11(1):37-44. PubMed ID: 11998550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.
    Matos C; van Hunsel F; Joaquim J
    Eur J Clin Pharmacol; 2015 Jul; 71(7):883-90. PubMed ID: 26004569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system.
    Ortega A; Aguinagalde A; Lacasa C; Aquerreta I; Fernández-Benítez M; Fernández LM
    Ann Pharmacother; 2008 Oct; 42(10):1491-6. PubMed ID: 18780808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An adverse drug event manager facilitates spontaneous reporting of adverse drug reactions.
    Vinther S; Klarskov P; Borgeskov H; Darsø P; Christophersen AK; Borck B; Christensen C; Hansen MV; Halladin NM; Christensen MB; Harboe KM; Lund M; Jimenez-Solem E
    Dan Med J; 2017 Jan; 64(1):. PubMed ID: 28007050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to promote adverse drug reaction reports using information systems - a systematic review and meta-analysis.
    Ribeiro-Vaz I; Silva AM; Costa Santos C; Cruz-Correia R
    BMC Med Inform Decis Mak; 2016 Mar; 16():27. PubMed ID: 26926375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linking Activity Theory Within User-Centered Design: Novel Framework to Inform Design and Evaluation of Adverse Drug Reaction Reporting Systems in Pharmacy.
    Fossouo Tagne J; Yakob RA; Mcdonald R; Wickramasinghe N
    JMIR Hum Factors; 2023 Feb; 10():e43529. PubMed ID: 36826985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
    Borg JJ; Aislaitner G; Pirozynski M; Mifsud S
    Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with spontaneous reporting of adverse drug reactions in Japan.
    Yamada T; Watanabe Y; Kusama M; Sugiyama Y; Ono S
    Pharmacoepidemiol Drug Saf; 2013 May; 22(5):468-76. PubMed ID: 23172714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous adverse drug reaction reporting by patients in Canada: a multi-method study-study protocol.
    Dweik RA; Yaya S; Stacey D; Kohen D
    Springerplus; 2016; 5():213. PubMed ID: 27026907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection.
    Trifirò G; Patadia V; Schuemie MJ; Coloma PM; Gini R; Herings R; Hippisley-Cox J; Mazzaglia G; Giaquinto C; Scotti L; Pedersen L; Avillach P; Sturkenboom MC; van der Lei J; Eu-Adr Group
    Stud Health Technol Inform; 2011; 166():25-30. PubMed ID: 21685607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacovigilance in China: development and challenges.
    Zhao Y; Wang T; Li G; Sun S
    Int J Clin Pharm; 2018 Aug; 40(4):823-831. PubMed ID: 30051225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The EU-ADR Web Platform: delivering advanced pharmacovigilance tools.
    Oliveira JL; Lopes P; Nunes T; Campos D; Boyer S; Ahlberg E; van Mulligen EM; Kors JA; Singh B; Furlong LI; Sanz F; Bauer-Mehren A; Carrascosa MC; Mestres J; Avillach P; Diallo G; Díaz Acedo C; van der Lei J
    Pharmacoepidemiol Drug Saf; 2013 May; 22(5):459-67. PubMed ID: 23208789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community Pharmacists' Views and Experiences with ADR Reporting for Complementary Medicines: A Qualitative Study in New Zealand.
    Barnes J; Butler R
    Drug Saf; 2020 Nov; 43(11):1157-1170. PubMed ID: 32975740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.